FDG-PET/CT in the staging of local/regional metastases in breast cancer

被引:55
作者
Robertson, Ian J. [1 ]
Hand, Fiona [1 ]
Kell, Malcolm R. [1 ]
机构
[1] Mater Misericordiae Univ Hosp, Eccles Breast Screening Unit, Dublin 7, Ireland
关键词
FDG-PET/CT; Breast cancer; Local/regional metastases; POSITRON-EMISSION-TOMOGRAPHY; LYMPH-NODE BIOPSY; MANAGEMENT; SCAN;
D O I
10.1016/j.breast.2011.07.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is the commonest female malignancy in the Western world and the most reliable predictor for survival is axillary lymph node metastases. Conventional staging techniques employed in breast cancer include mammography, ultrasonography, isotope bone scanning, sentinel lymph node biopsy, axillary lymph node dissection and magnetic resonance imaging. More recently FDG-PET and FDG-PET/CT have been used to complement the above methods. This review assesses the role of FOG-PET/CT in axillary staging ill patients with primary breast cancer. A PubMed search was conducted and all articles containing relevant or new information were included. Relevant studies examined identified that FOG-PET/CT has a sensitivity of 60% and a specificity of 97% in detecting lymphatic metastasis. Although positive axillary FOG-PET/CT is a good predictor of axillary disease and correlates well with SLNB, the relatively poor sensitivity (60%) must be considered for treatment planning. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:491 / 494
页数:4
相关论文
共 24 条
[1]  
Bedrosian I, 2000, CANCER, V88, P2540, DOI 10.1002/1097-0142(20000601)88:11<2540::AID-CNCR16>3.0.CO
[2]  
2-A
[3]   Role for Sentinel Lymph Node Dissection in the Management of Large (≥5 cm) Invasive Breast Cancer [J].
Mathew H. Chung ;
Wei Ye ;
Armando E. Giuliano .
Annals of Surgical Oncology, 2001, 8 (9) :688-692
[4]   Current surgical management of breast cancer [J].
Cody, HS .
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2002, 14 (01) :45-52
[5]   Detection of locoregional and distant recurrences in breast cancer patients by using FDG PET [J].
Eubank, WB ;
Mankoff, DA ;
Vesselle, HJ ;
Eary, JF ;
Schubert, EK ;
Dunnwald, LK ;
Lindsley, SK ;
Gralow, JR ;
Austin-Seymour, MM ;
Ellis, GK ;
Livingston, RB .
RADIOGRAPHICS, 2002, 22 (01) :5-17
[6]   Preoperative staging of large primary breast cancer with [18F] fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures [J].
Fuster, David ;
Duch, Joan ;
Paredes, Pilar ;
Velasco, Martin ;
Munoz, Montserrat ;
Santamaria, Gorane ;
Fontanillas, Montserrat ;
Pons, Francesca .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (29) :4746-4751
[7]   Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients [J].
Heusner, Till A. ;
Kuemmel, Sherko ;
Hahn, Steffen ;
Koeninger, Angela ;
Otterbach, Friedrich ;
Hamami, Monia E. ;
Kimmig, Klaus R. ;
Forsting, Michael ;
Bockisch, Andreas ;
Antoch, Gerald ;
Stahl, Alexander .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (10) :1543-1550
[8]   Is there a role for positron emission tomography in breast cancer staging? [J].
Hodgson, Nicole C. ;
Gulenchyn, Karen Y. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (05) :712-720
[9]   FDG-PET-CT for staging of high-risk breast cancer patients reduces the number of further examinations: A pilot study [J].
Jager, Jos ;
Keymeulen, Kristien ;
Beets-Tan, Regina G. H. ;
Hupperets, Pierre ;
Van Kroonenburgh, Marinus ;
Houben, Ruud ;
De Ruysscher, Dirk ;
Lambin, Philippe ;
Boersma, Liesbeth J. .
ACTA ONCOLOGICA, 2010, 49 (02) :185-191
[10]  
Kao CH, 2000, ANTICANCER RES, V20, P2189